Real-life use of cidofovir for the treatment of severe monkeypox cases

Journal of Medical VirologyVolume 95, Issue 1 e28218 LETTER TO THE EDITOR Real-life use of cidofovir for the treatment of severe monkeypox cases Angelo Roberto Raccagni, Corresponding Author Angelo Roberto Raccagni [email protected] orcid.org/0000-0001-7811-6255 Infectious Diseases Unit, Vita-Salute San Raffaele University, Milan, Italy Correspondence Angelo Roberto Raccagni, Vita-Salute San Raffaele University, Via Stamira D'Ancona 20, 20127 Milano, Italy. Email: [email protected]Search for more papers by this authorCaterina Candela, Caterina Candela Infectious Diseases Unit, Vita-Salute San Raffaele University, Milan, ItalySearch for more papers by this authorElena Bruzzesi, Elena Bruzzesi Infectious Diseases Unit, Vita-Salute San Raffaele University, Milan, ItalySearch for more papers by this authorDavide Mileto, Davide Mileto Laboratory of Clinical Microbiology, Virology and Bioemergencies, Ospedale Sacco, Milan, ItalySearch for more papers by this authorDiana Canetti, Diana Canetti Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, ItalySearch for more papers by this authorAlberto Rizzo, Alberto Rizzo Laboratory of Clinical Microbiology, Virology and Bioemergencies, Ospedale Sacco, Milan, Italy Laboratory of Clinical Microbiology, Virology and Bioemergencies, University of Milan, Milan, ItalySearch for more papers by this authorAntonella Castagna, Antonella Castagna Infectious Diseases Unit, Vita-Salute San Raffaele University, Milan, Italy Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, ItalySearch for more papers by this authorSilvia Nozza, Silvia Nozza Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, ItalySearch for more papers by this author Angelo Roberto Raccagni, Corresponding Author Angelo Roberto Raccagni [email protected] orcid.org/0000-0001-7811-6255 Infectious Diseases Unit, Vita-Salute San Raffaele University, Milan, Italy Correspondence Angelo Roberto Raccagni, Vita-Salute San Raffaele University, Via Stamira D'Ancona 20, 20127 Milano, Italy. Email: [email protected]Search for more papers by this authorCaterina Candela, Caterina Candela Infectious Diseases Unit, Vita-Salute San Raffaele University, Milan, ItalySearch for more papers by this authorElena Bruzzesi, Elena Bruzzesi Infectious Diseases Unit, Vita-Salute San Raffaele University, Milan, ItalySearch for more papers by this authorDavide Mileto, Davide Mileto Laboratory of Clinical Microbiology, Virology and Bioemergencies, Ospedale Sacco, Milan, ItalySearch for more papers by this authorDiana Canetti, Diana Canetti Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, ItalySearch for more papers by this authorAlberto Rizzo, Alberto Rizzo Laboratory of Clinical Microbiology, Virology and Bioemergencies, Ospedale Sacco, Milan, Italy Laboratory of Clinical Microbiology, Virology and Bioemergencies, University of Milan, Milan, ItalySearch for more papers by this authorAntonella Castagna, Antonella Castagna Infectious Diseases Unit, Vita-Salute San Raffaele University, Milan, Italy Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, ItalySearch for more papers by this authorSilvia Nozza, Silvia Nozza Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, ItalySearch for more papers by this author First published: 13 October 2022 https://doi.org/10.1002/jmv.28218Citations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Mahmoud A, Nchasi G. Monkeypox virus: a zoonosis of concern. J Med Virol. 2022. doi:10.1002/jmv.27968 2Siddiqui MO, Syed MA, Tariq R, Mansoor S. Multicounty outbreak of monkeypox virus—challenges and recommendations. J Med Virol. 2022. doi:10.1002/jmv.27966 3Baker RO, Bray M, Huggins JW. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res. 2003; 57(1-2): 13-23. 4Sherwat A, Brooks JT, Birnkrant D, Kim P. Tecovirimat and the treatment of monkeypox—past, present, and future considerations. N Engl J Med. 2022; 387: 579-581. doi:10.1056/NEJMp2210125 5Bragazzi NL, Kong JD, Mahroum N, et al. Epidemiological trends and clinical features of the ongoing monkeypox epidemic: a preliminary pooled data analysis and literature review. J Med Virol. 2022. doi:10.1002/jmv.27931 6Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox virus infection in humans across 16 countries—April–June 2022. N Engl J Med. 2022; 387: 679-691. doi:10.1056/NEJMoa2207323 Citing Literature Volume95, Issue1January 2023e28218 This article also appears in:Monkeypox and Related PoxvirusesMonkeypox Collection October 2022 ReferencesRelatedInformation